Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/197781
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAira Gómez, Andrea-
dc.contributor.authorRubio, Elisa-
dc.contributor.authorVergara Gómez, Andrea-
dc.contributor.authorCasals Pascual, Climent-
dc.contributor.authorRico, Verónica-
dc.contributor.authorSuñé i Negre, Josep M. (Josep Maria)-
dc.contributor.authorSoriano, Álex-
dc.date.accessioned2023-05-10T10:43:11Z-
dc.date.available2023-05-10T10:43:11Z-
dc.date.issued2022-
dc.identifier.issn2235-2988-
dc.identifier.urihttp://hdl.handle.net/2445/197781-
dc.description.abstractFecal microbiota transplantation (FMT) is one of the recommended treatments for recurrent Clostridioides difficile infection, but endoscopy and available oral formulations still have several limitations in their preparation, storage, and administration. The need for a viable oral formulation that facilitates the implementation of this highly effective therapy in different settings has led us to test the microcrystalline cellulose particles as an adsorbent of concentrated filtered fresh feces in comparison to lyophilized feces. This free-flowing material can provide protection to bacteria and results in a dried product able to maintain the viability of the microbiota for a long time. Adsorbate formulation showed a stabilizing effect in gut microbiota, maintaining bacteria viability and preserving its diversity, and is a competitive option for lyophilized capsules. Keywords: FMT; adsorbate; capsules; gut microbiota; lyophilization.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherFrontiers Media-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fcimb.2022.899257-
dc.relation.ispartofFrontiers in Cellular and Infection Microbiology, 2022, vol. 12, num. 1, p. 9-
dc.relation.urihttps://doi.org/10.3389/fcimb.2022.899257-
dc.rightscc-by (c) Aira Gómez, Andrea et al., 2022-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)-
dc.subject.classificationMicrobiota intestinal-
dc.subject.classificationLiofilització-
dc.subject.classificationMalalties bacterianes-
dc.subject.otherGastrointestinal microbiome-
dc.subject.otherFreeze-drying-
dc.subject.otherBacterial diseases-
dc.titleNew Procedure to Maintain Fecal Microbiota in a Dry Matrix Ready to Encapsulate-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec728310-
dc.date.updated2023-05-10T10:43:11Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina9316004-
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
728310.pdf5.27 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons